Laura Scalvini
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Iso- and Benzisothiazolinone Inhibitors of Monoacylglycerol Lipase: Exploring On-Target Activity Through Scaffold Decoration and In Situ Warhead Generation.
Journal: ChemMedChem
Published: May 26, 2026
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors.
Journal: Biochemical pharmacology
Published: December 18, 2025
N-Acylaminoethyltetrahydroquinolines: A new class of melatonin receptor ligands with in vivo activity on glioblastoma.
Journal: European journal of medicinal chemistry
Published: August 11, 2025
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells.
Journal: Bioorganic chemistry
Published: July 30, 2025
Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication.
Journal: Biochemical pharmacology
Published: May 29, 2025
Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics.
Journal: European journal of medicinal chemistry
Published: April 22, 2025
JAK3 Inhibitors: Covalent and Noncovalent Interactions of a Cyanamide Group Investigated by Multiscale Free-Energy Simulations.
Journal: Journal of chemical information and modeling
Published: January 17, 2025
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients.
Journal: ACS pharmacology & translational science
Published: July 26, 2024
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line.
Journal: European journal of medicinal chemistry
Published: February 26, 2024
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity.
Journal: Pharmacological research
Published: December 20, 2023
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity.
Journal: Journal of chemical information and modeling
Published: November 01, 2023
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence.
Journal: Journal of pineal research
Published: October 12, 2023
Last Updated: 09/26/2026